Craig McClain
University of Louisville
Appearances
DateMay 7, 2023Alcohol associated liver disease is still a very common entity. The session will provide a comprehensive approach to the aforementioned disease including clinical presentations, diagnosis and emerging treatments including liver transplant…Presenter
University of Louisville- DateMay 7, 2023Alcohol associated liver disease is still a very common entity. The session will provide a comprehensive approach to the aforementioned disease including clinical presentations, diagnosis and emerging treatments including liver transplant…
Presenters
University of LouisvilleBeth Israel Deaconess Medical CenterRutgers The State University of New Jersey 
DateMay 9, 2023SOCIETY: AASLDModerators
University of LouisvilleUniv. of Chicago Medicine- DateMay 8, 2023BACKGROUND: Alcohol-associated hepatitis (AH) is the active inflammatory state of alcohol-associated liver disease (ALD). AH varies in severity from mild to severe with mortality rates reaching 30-50% in severe AH…
Speakers
University of LouisvillePresenters
University of Louisville - DateMay 8, 2023BACKGROUND: Alcohol-associated hepatitis (AH) is the active inflammatory state of alcohol-associated liver disease (ALD). AH varies in severity from mild to severe with mortality rates reaching 30-50% in severe AH…
Speakers
University of LouisvillePresenter
University of Louisville FECAL EXTRACELLULAR VESICLES FROM ALD SUBJECTS EXACERBATED ALCOHOL-ASSCOCIATED LIVER DISEASE IN MICE
DateMay 20, 2024_OBJECTIVES_: Fecal microbiota transplantation (FMT) is a novel therapeutic strategy for alcohol-associated liver disease (ALD). However, adverse effects have been reported due to possible pathogenic bacteria colonization…Speakers
Presenter
